Minoxidil
Brand names: Loniten, Regaine (topical)
Minoxidil is a potent oral arterial vasodilator used for severe, treatment-resistant hypertension, usually in combination with other antihypertensives.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Its active sulphate metabolite opens ATP-sensitive potassium channels in arteriolar smooth muscle, causing relaxation and a fall in peripheral vascular resistance and blood pressure.
Prescribing in practice
- It causes marked fluid retention and reflex tachycardia, so it must almost always be co-prescribed with a diuretic and a beta-blocker (or other rate-controlling agent) to prevent oedema and angina.
- Pericardial effusion, occasionally progressing to tamponade, has been reported and warrants vigilance.
- Hypertrichosis is common and frequently leads to discontinuation, particularly in women; consult the SPC before prescribing.
Monitoring
Monitor blood pressure, heart rate, body weight and fluid status, watching for signs of pericardial effusion.
Counselling the patient
- Warn the patient about increased growth of body and facial hair, which is reversible on stopping.
- Advise reporting rapid weight gain, ankle swelling or breathlessness, and not to stop the medicine abruptly.
Evidence & guidelines
Oral minoxidil is reserved for resistant hypertension under specialist supervision; refer to current prescribing references.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Estimated Fetal Weight (Hadlock) · Fetal Growth
- Salter-Harris Classification of Physeal Fractures · Paediatric Fractures
- Tanner Staging (Sexual Maturity Rating) · Growth & Development
- Fenton Preterm Growth Chart (Gestational Age Correction) · Neonatology
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines